Physical Exercise for Hematopoietic Stem Cell Transplantation (HSCT)
HSCT
Feasibility and Safety of a Novel Individualized In-hospital Exercise Training Program for Patients Undergoing Hematopoietic Stem Cell Transplantation
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
Objective: To evaluate whether a novel individualized exercise training program for hospitalized patients undergoing hematopoietic stem cell transplantation (HSCT) is feasible and safe and whether it would improve functional capacity, muscle strength and health-related quality of life (HRQoL). Design: Prospective, within-group, feasibility intervention study. Setting: Bone marrow transplant unit in a general hospital. Subjects: Patients electively hospitalized for HSCT who were admitted to the bone marrow transplant unit. Intervention: Participants performed the individualized in-hospital exercise training program on a daily basis during their hospital admission. The exercise training program was performed once a day for 20 to 40 minutes and included a warm-up period, moderate-intensity aerobic exercise (10 to 20 minutes ), muscle strengthening exercise and cool-down activities. Outcome measures: The primary outcomes were feasibility (consent rate, attrition rate and exercise adherence) and the safety of the exercise program. Secondary outcomes included functional capacity (step test), peripheral muscle strength (sit-to-stand test) and HRQoL (QLQ-C30) were evaluated at baseline (on admission to hospital) and prior to hospital discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2017
CompletedFirst Submitted
Initial submission to the registry
August 14, 2018
CompletedFirst Posted
Study publicly available on registry
August 22, 2018
CompletedAugust 22, 2018
August 1, 2018
1 year
August 14, 2018
August 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
recruitment rates
recruitment rates was considered as the acceptance rate of patients eligible for the intervention to participate in the exercise regime - goal 60%
up to 4 weeks
attrition rates
attrition rates was considered as the acceptance rate of patients eligible for the intervention to participate in the exercise regime - until 30%
up to 4 weeks
exercise adherence rates
exercise adherence rates was assessed as the total number of minutes the participants performed the aerobic exercise in relation to the planned exercise time of at least 70%.
up to 4 weeks
adverse events rates
Safety of the intervention was considered if the adverse events rates was less than 5%
up to 4 weeks
Secondary Outcomes (4)
Functional capacity
up to 4 weeks
Lower limb muscle strength
up to 4 weeks
Upper limb muscle strength
up to 4 weeks
Health-related quality of life (HRQoL)
up to 4 weeks
Study Arms (1)
Intervention
OTHERPatients were eligible if they were aged 18 years or older, referred for HSCT and admitted to the Bone Marrow Transplant Unit (BMTU). Patients were screened in the BMTU admission and recruited to the study after avaliation in the first-day internation.
Interventions
The exercise training program was performed once daily, included 2- to 5-minute warm-up session (stretching, coordination and balance exercises), 10 to 20 minutes of moderate-intensity aerobic exercise using a cycle ergometer, 3 - to 5-sets to ten repetitions of sit-to-stand exercises with a 1-minute rest interval between each set. A cool-down period of 2- to 5-minutes of stretching and breathing exercises was delivered at the end of the exercise session. The aerobic training target zone was set at 50% to 70% of heart rate (HR) reserve.
Eligibility Criteria
You may qualify if:
- Patients were eligible for this study if they were aged 18 years or older
- And referred for HSCT and admitted to the Bone Marrow Transplant Unit (BMTU).
You may not qualify if:
- Patients were excluded if they were re-admitted to the hospital due to post-HSCT complications (infection, respiratory/cardiovascular complications, graft-versus-host disease - GVHD)
- Or diagnosed with any orthopedic and/or cognitive limitations that constrained the study assessments and/or training participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
FIORITTO
Federal University of Juiz de Fora
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator/ Post-Graduation Program on Collective Health
Study Record Dates
First Submitted
August 14, 2018
First Posted
August 22, 2018
Study Start
June 13, 2016
Primary Completion
June 15, 2017
Study Completion
June 15, 2017
Last Updated
August 22, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share